Floatz logo

RAMIFENTANYL

Anesthesia, General

Helse FonnaSmall moleculePhase 4 / ApprovedActive
BBB
73/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Anesthesia, General cohort.

Asset / SponsorPhaseRating
PROPOFOL
Helse Fonna
Phase 4BBB
EPHEDRINE, ANHYDROUS
Helse Fonna
Phase 4BB
MIVACURIUM ION
Helse Fonna
Phase 4BB
Noradrenaline
Helse Fonna
Phase 4BB
M-SYMPATHOL
Helse Fonna
Phase 4B

Same molecule, other indications

RAMIFENTANYL is also rated in:

morbid obesityDormant
BBB
Indicative ·
73 / 100
View asset →
cardiovascular disorderDormant
BBB
Indicative ·
73 / 100
View asset →
Anesthesia, LocalDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →